For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.
Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.
Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com.
The Manager of Pharmacokinetics will support the Clinical Pharmacology and Pharmacokinetics Team to provide analysis and interpretation of all pharmacokinetic and pharmacodynamic data and for the design of human and nonclinical studies.
Responsibilities:
- Serving as supporting role for both animal and human studies
- Conducting noncompartmental analyses of nonclinical and clinical data
- Plotting and evaluating animal and human pharmacokinetic data
- Contribute to authoring of pharmacokinetic and/or toxicokinetic reports
- Reviewing bioanalytical and method validation reports
- Participating in the support of regulatory submissions, including INDs, IBs and NDAs etc.
- Strictly adhering to agreed timelines to insure prompt and accurate execution of deliverables
- Participating in the development and authoring of study protocols, analysis plans, bioanalytical reports, and study reports
Preferred Skills, Qualifications and Technical Proficiencies:
- Hands-on and in-depth knowledge of current versions of pharmacokinetic and data analysis software programs such as Excel, Phoenix WinNonlin and GraphPad etc.
- Hands-on and in-depth knowledge of current versions PowerPoint and Word etc.
- Excellent written and oral communication skills
- Ability to adapt and problem solveConfidence to work in teams and to work independently
- Open to training and coaching from Team members
Preferred Education and Experience:
- 0-3 years of industry experience and a PhD, PharmD or MD degree with emphasis in pharmacokinetics, clinical pharmacology, or a related field
The pay range that the Company reasonably expects to pay for this headquarters-based position is $156,600 – $184,300; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
Applicants must be currently authorized to work in the United States on a full-time basis.
For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.
Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.
Please visit our website at: https://www.corcept.com/
Corcept is an Equal Opportunity Employer
Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.
Skills Required
- PhD, PharmD, or MD degree with emphasis in pharmacokinetics, clinical pharmacology, or a related field
- 0-3 years of industry experience
- Hands-on, in-depth knowledge of Excel, Phoenix WinNonlin, and GraphPad
- Hands-on, in-depth knowledge of PowerPoint and Word
- Excellent written and oral communication skills
- Ability to adapt and problem solve
- Ability to work in teams and independently
- Currently authorized to work full-time in the United States
What We Do
Leading the field in the discovery of drugs that modulate the effects of cortisol. The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol.
.jpeg)
